BrilliantStrings Therapeutics, Inc.
PrivateLast Round
Grant
Jun 23, 2025
Total Funding Raised
$2.95M
Company Overview
BrilliantStrings Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in June 2025.
BrilliantStrings Therapeutics, Inc. is a biotechnology company that develops injectable collagen-based mechanotherapeutic platforms for the repair of injured or degenerated connective tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrilliantStrings Therapeutics, Inc. Comparables
Compare BrilliantStrings Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CollaMedix Inc. | 76% | |
| Miach Orthopaedics | 75% | |
| Zimmer Biomet | 73% |
For institutional investors. Book with your work email.
BrilliantStrings Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2025 | ||||
| Series A | May 26, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrilliantStrings Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northeastern University Center for Research Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2025
$200K grant received from LabCentral.
For institutional investors. Book with your work email.
BrilliantStrings Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrilliantStrings Therapeutics, Inc.'s valuation, stock price, and market status.
Is BrilliantStrings Therapeutics, Inc. a public or private company?
BrilliantStrings Therapeutics, Inc. is a private company.
What is the current stock price of BrilliantStrings Therapeutics, Inc.?
BrilliantStrings Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks BrilliantStrings Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrilliantStrings Therapeutics, Inc. worth (valuation)?
Valuation information for BrilliantStrings Therapeutics, Inc. is not publicly available.
Can I buy BrilliantStrings Therapeutics, Inc. stock?
BrilliantStrings Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrilliantStrings Therapeutics, Inc.'s last funding round?
BrilliantStrings Therapeutics, Inc.'s most recent funding round was Grant on June 23, 2025.
Who are the main investors in BrilliantStrings Therapeutics, Inc.?
Key investors in BrilliantStrings Therapeutics, Inc. include Northeastern University Center for Research Innovation.
Will BrilliantStrings Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for BrilliantStrings Therapeutics, Inc..
How can I track BrilliantStrings Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BrilliantStrings Therapeutics, Inc.'s shares on secondary markets.